ATE218064T1 - Immunogene tlp-zusammensetzung - Google Patents

Immunogene tlp-zusammensetzung

Info

Publication number
ATE218064T1
ATE218064T1 AT97945086T AT97945086T ATE218064T1 AT E218064 T1 ATE218064 T1 AT E218064T1 AT 97945086 T AT97945086 T AT 97945086T AT 97945086 T AT97945086 T AT 97945086T AT E218064 T1 ATE218064 T1 AT E218064T1
Authority
AT
Austria
Prior art keywords
seq
immunogenic
tlp
composition
tlp composition
Prior art date
Application number
AT97945086T
Other languages
English (en)
Inventor
Giulio Tarro
Original Assignee
Unihart Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unihart Corp filed Critical Unihart Corp
Application granted granted Critical
Publication of ATE218064T1 publication Critical patent/ATE218064T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00Cellular immunotherapy
    • A61K40/10Cellular immunotherapy characterised by the cell type used
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00Cellular immunotherapy
    • A61K40/40Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41Vertebrate antigens
    • A61K40/42Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/80Vaccine for a specifically defined cancer
    • A61K2039/86Lung
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/80Vaccine for a specifically defined cancer
    • A61K2039/892Reproductive system [uterus, ovaries, cervix, testes]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/46Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
    • A61K2239/55Lung

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT97945086T 1996-10-09 1997-10-09 Immunogene tlp-zusammensetzung ATE218064T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96RM000687A IT1294967B1 (it) 1996-10-09 1996-10-09 Composizione immunogenica da tlp
PCT/IT1997/000240 WO1998015282A1 (en) 1996-10-09 1997-10-09 Immunogenic tlp composition

Publications (1)

Publication Number Publication Date
ATE218064T1 true ATE218064T1 (de) 2002-06-15

Family

ID=11404462

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97945086T ATE218064T1 (de) 1996-10-09 1997-10-09 Immunogene tlp-zusammensetzung

Country Status (17)

Country Link
US (2) US20020031531A1 (de)
EP (1) EP0938329B1 (de)
JP (1) JP2001508764A (de)
KR (1) KR20000048995A (de)
CN (1) CN1239431A (de)
AT (1) ATE218064T1 (de)
AU (1) AU725218B2 (de)
CA (1) CA2267905A1 (de)
DE (2) DE69712907T2 (de)
DK (1) DK0938329T3 (de)
ES (1) ES2138574T3 (de)
IL (1) IL129368A0 (de)
IT (1) IT1294967B1 (de)
NO (1) NO991653L (de)
PT (1) PT938329E (de)
RU (1) RU2192274C2 (de)
WO (1) WO1998015282A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1317853B1 (it) * 2000-02-25 2003-07-15 Unihart Corp Peptidi tlp e sequenze di dna che li codificano.
RU2192884C2 (ru) * 2000-11-09 2002-11-20 Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН Вакцина для стимуляции противоопухолевого иммунитета
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
JP2008526194A (ja) 2004-12-30 2008-07-24 ヴィート ミケーレ ファツィオ 抗腫瘍免疫原性ペプチド及びそのワクチン
WO2009085277A2 (en) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Treatment of abnormal or excessive scars
ITRM20100256A1 (it) * 2010-05-19 2011-11-20 Farmafin Spa Un nuovo biomarcatore per la diagnosi precoce e l'immunoterapia del cancro
EP3167898A1 (de) 2015-11-11 2017-05-17 IEO - Istituto Europeo di Oncologia Srl Verfahren zur gewinnung von tumorpeptiden und verwendungen davon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1206250B (it) * 1987-02-18 1989-04-14 Ist Farmacoterapico It Spa Stiche umane e relativi prodotti metodo per l'estrazione di antigeni di membrana aventi proprieta' immunogene a partire da cellule neopla-
IT1262954B (it) * 1992-07-03 1996-07-23 Ist Farmacoterapico It Spa Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.

Also Published As

Publication number Publication date
US20040022870A1 (en) 2004-02-05
IT1294967B1 (it) 1999-04-23
NO991653D0 (no) 1999-04-08
IL129368A0 (en) 2000-02-17
KR20000048995A (ko) 2000-07-25
EP0938329A1 (de) 1999-09-01
WO1998015282A1 (en) 1998-04-16
ES2138574T3 (es) 2002-11-01
AU4637697A (en) 1998-05-05
US20020031531A1 (en) 2002-03-14
PT938329E (pt) 2002-10-31
ES2138574T1 (es) 2000-01-16
CA2267905A1 (en) 1998-04-16
DE69712907T2 (de) 2002-12-12
CN1239431A (zh) 1999-12-22
DE69712907D1 (de) 2002-07-04
AU725218B2 (en) 2000-10-05
EP0938329B1 (de) 2002-05-29
NO991653L (no) 1999-06-08
RU2192274C2 (ru) 2002-11-10
DE938329T1 (de) 2000-04-06
JP2001508764A (ja) 2001-07-03
DK0938329T3 (da) 2002-09-09
ITRM960687A1 (it) 1998-04-09

Similar Documents

Publication Publication Date Title
EP2258383A3 (de) Von der Telomerase abgeleitete antigene Peptide
HUP9901186A2 (hu) Peptid-és adjuvánsalapú gyógyszerkészítmény immunmodulációra
EP1484339A3 (de) Kallikreinhemmende "Kunitz-Domäne"Proteine dafür kodierende Nukleinsäure
NZ516381A (en) Lung tumor proteins in the therapy and diagnosis of lung cancer
DE69731373D1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
BG102983A (en) Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application
WO1998033509A3 (en) Useful properties of human lactoferrin and variants thereof
DE69922822D1 (de) Rekombinante haarbehandlungsmittel
NZ279963A (en) Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
CA2234263A1 (fr) Composition pharmaceutique contre les tumeurs et infections a papillomavirus
DK1025236T3 (da) Human checkpoint kinase, HCDS1, præparater og fremgangsmåde
WO1997022695A3 (fr) Sequences nucleotidiques, proteines, medicaments et agents diagnostiques utiles dans le traitement du cancer
DE69931482D1 (de) Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
DE69712907D1 (de) Immunogene tlp-zusammensetzung
DE60118359D1 (de) Humanische pellino-polypeptide
EP1401467A4 (de) Alpha-fetoprotein-peptide und ihre verwendung
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
NZ518772A (en) Polypeptide fragments comprising c-terminal portion of helicobacter catalase
AU3711597A (en) A novel galanin receptor
PT782630E (pt) Gene da doenca poliquistica do rim
GB2357507A (en) Peptide fragments of cholera toxin B or enterotoxin B as vaccine adjuvants
NO20011263L (no) Moraxella Catarrhalis BASBO34-polypeptider og anvendelser derav
WO1999031229A3 (en) Peptides and nucleic acids derived from eisenia foetida and the use thereof
DE60036676D1 (de) G-protein-gekoppelter rezeptor-ähnliche proteine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee